Estradiol/​Norgestimate

DEA Class; Rx

Common Brand Names; Cilest, Prefest

  • Estrogens/Progestins-HRT

Combination oral product; estradiol is the principal human circulating estrogen; norgestimate is a progestin of high progestational and low androgenic activity
Norgestimate is added to estrogen therapy to reduce risk for endometrial hyperplasia
Primarily used together in women with an intact uterus to treat moderate to severe vasomotor and genitourinary symptoms associated with menopause and for the prevention of osteoporosis

Indicated for treatment of moderate to severe vasomotor symptoms (hot flashes) of menopause and/or related genitourinary symptoms including atrophic vaginitis, vulvar atrophy (kraurosis vulvae) in women with an intact uterus.
For postmenopausal osteoporosis prophylaxis in women with an intact uterus.

Hypersensitivity

Pregnancy

Estrogen-dependent neoplasia

Current/history of: DVT/PE, arterial thromboembolic disease, breast cancer, liver disease/tumours

Undiagnosed abnormal vaginal bleeding

Jaundice with previous OCP use

Porphyria

History of pruritus gravidarum, pemphigoid gestationis, deterioration of otosclerosis or idiopathic jaundice during pregnancy

Untreated endometrial hyperplasia

Common

  • Headache

  • Breast pain

  • Abdominal pain

  • Back pain

  • URI

  • Influenza-like symptoms

Less common

  • Cardiovascular disease

  • Deep vein thrombosis

  • Hypertension

  • Breast cancer

  • Endometrial neoplasia

  • Gallbladder disease

Bone mineral density changes, current/history of depression, DM, HTN, hyperlipidemia, hypertriglyceridemia, obesity, endometriosis, family history of breast cancer and DVT/PE, smoking, epilepsy, migraine, renal impairment, severe hypocalcemia, ovarian cancer

Discontinue if the following develop: jaundice, visual problems, 4-6 wk before major surgery, any symptoms of VTE, massive BP increases, unusually severe migraines or first-time migraines, depression

Increased risk of post-op thromboembolic complications

Conditions exacerbated by fluid retention (eg, asthma, migraine, cardiac/renal dysfunction, epilepsy)

Patients on warfarin/oral anticoagulants: Estrogens increase thromboembolic risk; increase in anticoagulant dose may be warranted

History of migraine with aura

Cholelithiasis

Risk of developing dementia

Monitor blood pressure

Pregnancy Category: X

Lactation: enters breast milk; use with caution

Adults

1 tablet/day PO, in the order directed on the blister card (e.g., Prefest).

Geriatric

1 tablet/day PO, in the order directed on the blister card (e.g., Prefest).

Adolescents

Not indicated.

Children

Not indicated.

Estradiol/norgestimate

tablet

  • Pink: 1mg (15 tabs)
  • White: 1mg/0.09mg (15 tabs)

About the Author

You may also like these

0